- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-05
DOI
10.3389/fonc.2019.00246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1)
- (2018) Patricia Santofimia-Castaño et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
- (2018) Susan Tsai et al. BMC CANCER
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
- (2018) Manjusha Thakar et al. PLoS One
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
- (2018) Hervé Tiriac et al. Cancer Discovery
- Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
- (2018) Mao-Hua Cai et al. Scientific Reports
- Cancer epigenetics: Moving forward
- (2018) Angela Nebbioso et al. PLoS Genetics
- Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model
- (2018) Elaine C. Maggi et al. Frontiers in Genetics
- Role of Gene Therapy in Pancreatic Cancer—A Review
- (2018) Mizuho Sato-Dahlman et al. Cancers
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth By Inducing Mitotic Catastrophe
- (2017) Angela Mathison et al. MOLECULAR CANCER RESEARCH
- SWI/SNF complex in cancer
- (2017) Chao Lu et al. NATURE GENETICS
- Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B
- (2017) Patricia Santofimia-Castaño et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
- (2017) Rémy Nicolle et al. Cell Reports
- Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
- (2017) Anup Sharma et al. PLoS One
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster
- (2016) S. Zagorac et al. CANCER RESEARCH
- GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
- (2016) Paola Martinelli et al. GUT
- Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy
- (2016) Saini Setua et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Safety and efficacy of ezetimibe: A meta-analysis
- (2015) Gianluigi Savarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- First-in-man Phase 1 Clinical Trial of Gene Therapy for Advanced Pancreatic Cancer: Safety, Biodistribution, and Preliminary Clinical Findings
- (2015) Louis Buscail et al. MOLECULAR THERAPY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- The selection and function of cell type-specific enhancers
- (2015) Sven Heinz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
- (2015) Fabienne Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
- (2015) Yue Zhao et al. Targeted Oncology
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis
- (2015) Hongqiang Chen et al. Scientific Reports
- Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
- (2015) Monika Bauden et al. Clinical Epigenetics
- A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor
- (2015) Odile Gayet et al. Oncotarget
- A microRNA meta-signature for pancreatic ductal adenocarcinoma
- (2014) Adam E Frampton et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
- (2014) Katia Nones et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
- (2014) MAKOTO ABUE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
- (2013) J. M. Yi et al. CLINICAL CANCER RESEARCH
- Non-coding RNAs as direct and indirect modulators of epigenetic regulation
- (2013) Veronica J Peschansky et al. Epigenetics
- Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
- (2013) Jun Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Abstract LB-214: Interim results from a randomized Phase 1-2 first-in-human (FIH) study of PK/PD guided escalating doses of SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA) in relapsed/refractory MDS and AML
- (2012) Jean Pierre Issa et al. CANCER RESEARCH
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
- (2011) D. Pramanik et al. MOLECULAR CANCER THERAPEUTICS
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma
- (2010) Baojin Fu et al. CANCER BIOLOGY & THERAPY
- The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis
- (2010) N. Hanoun et al. CLINICAL CHEMISTRY
- Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
- (2009) Daniela E. Matei et al. GYNECOLOGIC ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Methylation profile of circulating plasma DNA in patients with pancreatic cancer
- (2008) Anatoliy A. Melnikov et al. JOURNAL OF SURGICAL ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started